e-learning
resources
Munich 2006
Monday 04.09.2006
Community-acquired pneumonia: risk factors and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia
F. Sanz, J. Blanquer, M. L. Briones, R. Blanquer, E. Chiner, C. Aguar (Valencia, Spain)
Source:
Annual Congress 2006 - Community-acquired pneumonia: risk factors and treatment
Session:
Community-acquired pneumonia: risk factors and treatment
Session type:
Poster Discussion
Number:
2092
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Sanz, J. Blanquer, M. L. Briones, R. Blanquer, E. Chiner, C. Aguar (Valencia, Spain). Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia. Eur Respir J 2006; 28: Suppl. 50, 2092
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Thrombocytosis is a marker of poor outcome in community-acquired pneumonia
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Prediction of prognosis in healthcare-associated pneumonia
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Biomarkers as complication predictors in community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010
Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Prognostic factors of bacteremic pneumococcal pneumonia (BPP)
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept